Oct. 08. 2019
Upsher-Smith Launches Tosymra™ (sumatriptan) Nasal Spray for the Acute Treatment of Migraine in Adults
Jul. 22. 2019
Upsher-Smith Laboratories Completes Acquisition of Two Treatments for Acute Migraine in Adults
Jun. 21. 2019
Osteoporosis drug "Minodronic Acid Tablets 50 mg [SAWAI]" wins "World Star Awards" in a prestigious packaging contest.
Jun. 14. 2019
Upsher-Smith Laboratories Enters Into Agreement to Acquire Tosymra™ and Zembrace® Symtouch®
Feb. 13. 2019
An interview with Mitsuo Sawai (President of Sawai Pharmaceutical Co., Ltd.) was published in 2019 Japan Business Report in the South China Morning Post.